budesonide

(redirected from Pulmicort Respules)
Also found in: Medical.
Translations
budesonid

budesonide

n budesonida, budesónida (INN)
References in periodicals archive ?
I like this little complimentary book provided by AstaZeneca Manufacturers of the Pulmicot Turbuhaler an inhalation powder and Pulmicort Respules inhalation suspension.
The plant currently produces respiratory medicines, such as Pulmicort Respules for asthma patients.
The decision by the court in New Jersey as well ruled that AstraZeneca's request for a permanent injunction is refused, opening the way for Actavis' copy of Pulmicort Respules (budesonide) as it does not infringe the 834 patent .
AstraZeneca also announced that a US federal appeals court had issued a temporary injunction blocking generic manufacturers from distributing versions of Pulmicort Respules, an asthma treatment.
AstraZeneca has full confidence in the strength of its intellectual property rights protecting Pulmicort Respules.
Generic competition for Pulmicort Respules for asthma and Toprol-XL blood-pressure treatment also hurt sales.
The Anglo-Swedish pharma major will pay USD13m to two classes of plaintiffs -- third-party payers who paid some or all of their Medicare co-insurance for its cancer drug Zoladex and/or its asthma treatment Pulmicort Respules in the northeastern US state of Massachusetts as well as consumers and third-party payers who paid cash or a co-pay for these drugs outside of Medicare in Massachusetts.
The London-based company made the decision based in part on new generic competition against asthma drug Pulmicort Respules, which is manufactured in Westboro.
from launching a generic version of AstraZeneca's PULMICORT RESPULES (budesonide inhalation suspension) in the US.
The launch of a generic version of Mirapex and continued strong sales from existing products like generic versions of Pulmicort Respules, Adderall XR, Accutane, and Eloxatin helped North American revenues grow 20% to $2,309 million.
M2 EQUITYBITES-March 10, 2016-Teva introduces generic Pulmicort Respules in third strength in the US
M2 PHARMA-March 10, 2016-Teva introduces generic Pulmicort Respules in third strength in the US